SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-087321
Filing Date
2023-08-03
Accepted
2023-08-03 16:34:24
Documents
6
Period of Report
2023-09-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232384-3_def14a.htm DEF 14A 684806
2 GRAPHIC bc_netincome-4clr.jpg GRAPHIC 154875
3 GRAPHIC bc_tsr-4clr.jpg GRAPHIC 159989
4 GRAPHIC px_armatapxy01pg01-bw.jpg GRAPHIC 737196
5 GRAPHIC px_armatapxy01pg02-bw.jpg GRAPHIC 676159
6 GRAPHIC sg_robinckramer-bw.jpg GRAPHIC 19831
  Complete submission text file 0001104659-23-087321.txt   2825040
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 231140667
SIC: 2836 Biological Products, (No Diagnostic Substances)